Suppression of MD2 inhibits breast cancer in vitro and in vivo

PURPOSE: To explore the effects of the intervening measure targeting myeloid differentiation 2 (MD2) on breast cancer progression in vitro and in vivo. METHODS: The expression of MD2 in normal breast cells (Hs 578Bst) and three kinds of breast carcinoma cell lines (MCF-7, MDA-MB-231 s and 4T1) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, S., Fu, W., Ma, R., Huang, Q., Gu, J., Zhou, J., Lu, K., Guo, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310507/
https://www.ncbi.nlm.nih.gov/pubmed/33733435
http://dx.doi.org/10.1007/s12094-021-02587-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310507/
https://www.ncbi.nlm.nih.gov/pubmed/33733435
http://dx.doi.org/10.1007/s12094-021-02587-9

Ejemplares similares